Alternate Cancer Remedies
cago; he wanted to meet Dr. Andrew C. Ivy, one of the most prominent physicians in America. Durovic had recently discovered a paper by Ivy on a theory behind cancer formation, which agreed remarkably with his own.
During World War II, Andrew C. Ivy, M.D., had been chosen by the government to set up the vast Naval Medical Research Institute at Bethesda, Maryland. During World War II, he had been se- lected by the American Medical Association’s Board of Trustees and the U.S. Government, to repre- sent the allied governments in the trials of Ger- man medical men. On his return from Europe, he accepted a position as vice-president of the Uni- versity of Illinois, and in charge of its huge medi- cal school. Powerfully built, Ivy was a man of ut- most integrity, courage, and determination. If he believed a cause was right, he had the personality of a bulldog in carrying it through.
Ivy also believed, and had written, that if the uncontrolled growth of cancer could be sur- mounted, the disease could be conquered.
When Durovic landed at the Chicago airport, he was in a strange land and could not speak a word of English. At the airport, he was met by two Chicago businessmen, Edwin Moore and Kenneth Brainard, Moore’s brother-in-law.
The men were kind to him and Brainard spoke French, which Durovic knew well. They offered to fund his work, if he would sign over certain rights to his work.
But, somehow, amid all the dickering, an as- pect of confusion arose. Durovic was willing to sign over Kositerin for high blood pressure, but not Krebiozen for cancer. Yet they were his transla- tors, and so became involved in Krebiozen also. We will not here give much attention to this mat- ter, except to say that Brainard and Moore were later to give Durovic a lot of trouble when they demanded full distribution rights to the substance.
It was the summer of 1949, and Durovic came to see Dr. Ivy. As soon as he heard about the bio- logic rationale of Kositerin, Ivy agreed to test it.
Shortly afterward, Durovic received word from Dr. Da Grana, back in Buenos Aires, who had just completed some key testing of Krebiozen on dogs. It was an astounding success against the cancers, and had even cleared up the cataracts on six of the dog’s eyes; they could see again!
Durovic felt he was now ready to speak to An- drew C. Ivy about Krebiozen. On an August after- noon, as always accompanied by Moore and Brainard, he held a conference with Ivy in his of- fice of the vice president.
Durovic requested that Kositerin testing be sidelined for a while and Krebiozen be tested. When Ivy heard about the Argentinian results so far, he was deeply interested, and inquired how it was made. But Durovic said he could not say, since business interests were involved. This caused Ivy to hesitate.
So Durovic told him part of the information: More than two grams of Kositerin had been ex- tracted from a comparatively small number of cattle; and Krebiozen, of which there were only two grams, had been extracted in a similar man- ner from many hundreds of horses.
Even though the formula was secret, Ivy de- cided that he would go ahead with the experimen- tation, but do it privately through physician friends rather than through the University Medical School.
The rest of the story has filled entire books (including K-Krebiozen—Key to Cancer? and A Matter of Life or Death, both by Herbert Bailey).
Krebiozen is derived from Greek words which mean “that which regulates growth.”
Tests on humans were begun—and the results were astounding. Many recoveries occurred. Then the American Medical Association, following a cur- sory meeting or two, denounced Krebiozen as use- less in a report released through its Journal. Ivy quickly found his closest medical friends separat- ing from him.
The extent of the problem can be gleaned from the fact that, on March 15, 1954, ten dying pa- tients who had received Krebiozen and later had been certified in the AMA report as dead wrote a letter to the chairman of the Krebiozen Investigat- ing Committee, that they were alive and in excel- lent health.
A great variety of events and counter-events followed; far too many to relate here. Cancer pa- tients, who had been healed, testified. The whole affair was in the public press throughout the na- tion, generally with Ivy not appearing in a very good light. Charges and counter-charges were made. Moore and Brainard stirred up trouble.
Even close physician friends who had carried out favorable experiments with Krebiozen retracted and said it was useless. Andrew C. Ivy was fired from the University; and, in 1954, Dr. George D. Stoddard, president of the University was dis- charged for not separating quickly enough from Ivy.
Eventually, Durovic’s small supply of Krebio- zen ran out—especially after he and Ivy discov- ered that they had not been giving large enough doses to the patients. When that was done, the recovery rate became much higher—but the am- pules were more rapidly used up.